Results 321 to 330 of about 4,282,960 (349)

High-cost generic drugs--implications for patients and policymakers.

New England Journal of Medicine, 2015
K. Uhl, John R. Peters, Keith Flanagan
semanticscholar   +1 more source

Functional Imaging of Cancer with Emphasis on Molecular Techniques

Ca-A Cancer Journal for Clinicians, 2007
Mohamed Houseni
exaly  

Multiple Myeloma: Charging Toward a Bright Future

Ca-A Cancer Journal for Clinicians, 2007
Parameswaran N Hari
exaly  

Clinical development of novel therapeutics for castration‐resistant prostate cancer

Ca-A Cancer Journal for Clinicians, 2012
Matthew D Galsky, Alexander C Small, William K Oh   +2 more
exaly  

Preventing Occupational Exposures to Antineoplastic Drugs in Health Care Settings

Ca-A Cancer Journal for Clinicians, 2006
exaly  

The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs

Chemical Reviews, 2016
Timothy C Johnstone, Kogularamanan Suntharalingam, Stephen J Lippard   +2 more
exaly  

Bioequivalence of generic drugs.

Journal of Clinical Psychiatry, 2015
C. Andrade
semanticscholar   +1 more source

Combining epigenetic drugs with other therapies for solid tumours — past lessons and future promise

Nature Reviews Clinical Oncology, 2019
Daphné Morel, Daniel Jeffery, Sandrine Aspeslagh   +2 more
exaly  

Creating New Economic Incentives for Repurposing Generic Drugs for Unsolved Diseases Using Social Finance

Assay and drug development technologies, 2015
Bruce Bloom
semanticscholar   +1 more source

Cancer, obesity, diabetes, and antidiabetic drugs: is the fog clearing?

Nature Reviews Clinical Oncology, 2016
Adi J Klil-Drori, Laurent Azoulay, Michael N Pollak   +2 more
exaly